Diversity Segmentation

(redirected from heterogeneity)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

Diversity Segmentation

The use of a cost driver (which is a factor that directly contributes to a company's expenses) to account for changing demand.
References in periodicals archive ?
4, our fractional logit analysis generally finds the same types of heterogeneity significant under analogous specifications, although often with smaller marginal effects.
Farrell and Hersch (2005) examine gender heterogeneity and find women board members have no influence on firm performance.
We agreed that HER2 genetic heterogeneity (GH) existed when between 5% and 50% of infiltrating tumor cells demonstrated gene amplification (a ratio of 2.
Again, the width of the curve does not reflect the heterogeneity of the (geometric parameter, or property of the) material, but merely of the sampling scale.
Deliberate heterogeneity is the result of a staffing decision about what knowledge or expertise is necessary to accomplish the team's task.
f] is a measure of heterogeneity in the solution and that PAN 1, 3, 4, and 5 have similar molecular weight, it is inferred that homo-polymers (PAN 1) have least heterogeneity issues in comparison to co-polymers (PAN 3, 4, and 5) .
Biology of genetic & epigenetic heterogeneity and impact on outcome in chronic lymphocytic leukemia (CLL)
Other experiments have argued that the non-Nash behavior is reduced by heterogeneity in wealth levels (Buckley and Croson 2006; Chan et al.
This paper aims to examine the influence of heterogeneity on growth and therefore provide new empirical evidence by analyzing the channels through which ethnic heterogeneity affects growth.
The updated estimates for the effect of income on the timing and spacing of the first three births are robust to individual-level heterogeneity and endogeneity of income.
Given this emerging evidence for intratumor heterogeneity in somatic mutational status between sites of disease and for the risks associated with biopsying multiple sites of disease (6, 14), it is critical to determine how less-invasive techniques can be established to profile a tumor's somatic mutational load more rapidly and to track its evolution over time.
We also find a great deal of heterogeneity in returns across funds and time.